TWD 17.5
(1.74%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.41 Billion TWD | -682.62% |
2022 | 50.93 Million TWD | -89.32% |
2021 | 487.19 Million TWD | -63.99% |
2020 | 1.35 Billion TWD | 341.59% |
2019 | 306.12 Million TWD | 11.34% |
2018 | 272.63 Million TWD | -38.82% |
2017 | 448.91 Million TWD | 654.38% |
2016 | -78.72 Million TWD | -116.38% |
2015 | 495.97 Million TWD | 6.16% |
2014 | 469.04 Million TWD | -5.71% |
2013 | 487.86 Million TWD | -8.34% |
2012 | 536.6 Million TWD | -12.73% |
2011 | 614.47 Million TWD | 9.6% |
2010 | 566.97 Million TWD | -29.48% |
2009 | 789.47 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -29.92 Million TWD | 69.98% |
2024 Q2 | -20.14 Million TWD | 95.68% |
2023 Q3 | 1.71 Billion TWD | 1139.01% |
2023 Q4 | -105.14 Million TWD | -106.15% |
2023 Q1 | -34.4 Million TWD | 34.09% |
2023 Q2 | -164.66 Million TWD | -378.65% |
2023 FY | - TWD | -682.62% |
2022 Q3 | 28.99 Million TWD | 862.9% |
2022 FY | - TWD | -89.32% |
2022 Q1 | 72.22 Million TWD | -2.89% |
2022 Q2 | 3.01 Million TWD | -95.83% |
2022 Q4 | -52.19 Million TWD | -280.02% |
2021 FY | - TWD | -63.99% |
2021 Q1 | 130.09 Million TWD | -58.86% |
2021 Q3 | 99.94 Million TWD | -45.31% |
2021 Q4 | 74.37 Million TWD | -25.59% |
2021 Q2 | 182.77 Million TWD | 40.49% |
2020 FY | - TWD | 341.59% |
2020 Q4 | 316.21 Million TWD | -42.45% |
2020 Q1 | 165.74 Million TWD | 46.62% |
2020 Q2 | 321.48 Million TWD | 93.97% |
2020 Q3 | 549.45 Million TWD | 70.91% |
2019 FY | - TWD | 11.34% |
2019 Q2 | 52.81 Million TWD | -45.59% |
2019 Q4 | 113.04 Million TWD | 160.15% |
2019 Q3 | 43.45 Million TWD | -17.72% |
2019 Q1 | 97.06 Million TWD | 81.86% |
2018 Q4 | 53.37 Million TWD | -8.48% |
2018 Q2 | 54.66 Million TWD | -49.75% |
2018 FY | - TWD | -38.82% |
2018 Q1 | 108.8 Million TWD | 35.95% |
2018 Q3 | 58.32 Million TWD | 6.68% |
2017 Q4 | 80.03 Million TWD | -52.03% |
2017 FY | - TWD | 654.38% |
2017 Q3 | 166.82 Million TWD | 47.38% |
2017 Q2 | 113.19 Million TWD | 26.2% |
2017 Q1 | 89.69 Million TWD | 121.11% |
2016 FY | - TWD | -116.38% |
2016 Q4 | -424.94 Million TWD | -504.64% |
2016 Q3 | 105.01 Million TWD | -19.66% |
2016 Q2 | 130.71 Million TWD | 20.93% |
2016 Q1 | 108.08 Million TWD | -13.52% |
2015 Q3 | 119.9 Million TWD | -3.05% |
2015 Q4 | 124.98 Million TWD | 4.24% |
2015 Q2 | 123.67 Million TWD | -2.5% |
2015 Q1 | 126.84 Million TWD | 6.23% |
2015 FY | - TWD | 6.16% |
2014 Q1 | 118.84 Million TWD | -2.97% |
2014 FY | - TWD | -5.71% |
2014 Q4 | 119.4 Million TWD | 7.14% |
2014 Q3 | 111.44 Million TWD | -4.72% |
2014 Q2 | 116.96 Million TWD | -1.58% |
2013 Q3 | 94.09 Million TWD | -24.36% |
2013 Q4 | 122.48 Million TWD | 30.17% |
2013 FY | - TWD | -8.34% |
2013 Q1 | 153.95 Million TWD | 115.13% |
2013 Q2 | 124.39 Million TWD | -19.2% |
2012 Q4 | 71.56 Million TWD | -59.73% |
2012 Q2 | 131.94 Million TWD | -24.81% |
2012 Q1 | 175.47 Million TWD | 18.55% |
2012 Q3 | 177.69 Million TWD | 34.68% |
2012 FY | - TWD | -12.73% |
2011 Q1 | 169.37 Million TWD | 22.75% |
2011 Q2 | 186.42 Million TWD | 10.07% |
2011 Q3 | 114.85 Million TWD | -38.39% |
2011 Q4 | 148.01 Million TWD | 28.87% |
2011 FY | - TWD | 9.6% |
2010 FY | - TWD | -29.48% |
2010 Q3 | 121.17 Million TWD | -7.38% |
2010 Q2 | 130.83 Million TWD | -25.02% |
2010 Q1 | 174.48 Million TWD | 0.0% |
2010 Q4 | 137.98 Million TWD | 13.87% |
2009 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Farcent Enterprise Co.,Ltd | 355.04 Million TWD | -298.69% |
Mao Bao Inc. | 9.01 Million TWD | -15602.119% |
Taiyen Biotech Co., Ltd. | 518.26 Million TWD | -173.132% |
Sanitar Co., Ltd. | 401.77 Million TWD | -252.321% |
Chlitina Holding Limited | 1.96 Billion TWD | 28.101% |
Jourdeness Group Limited | 802.68 Million TWD | -76.351% |
Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | -77.209% |
Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -1072.732% |
San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -320.775% |
Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 15.289% |